nodes	percent_of_prediction	percent_of_DWPC	metapath
Roxatidine acetate—HRH2—Histamine receptors—HRH1—atherosclerosis	0.439	0.439	CbGpPWpGaD
Roxatidine acetate—HRH2—Monoamine GPCRs—HRH1—atherosclerosis	0.0811	0.0811	CbGpPWpGaD
Roxatidine acetate—HRH2—Amine ligand-binding receptors—HRH1—atherosclerosis	0.0682	0.0682	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.0157	0.0157	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.0134	0.0134	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—HRH1—atherosclerosis	0.0102	0.0102	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.0097	0.0097	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.00967	0.00967	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.00899	0.00899	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.00864	0.00864	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.00829	0.00829	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.00813	0.00813	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.0077	0.0077	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CCL4—atherosclerosis	0.00738	0.00738	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.00699	0.00699	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.00699	0.00699	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00662	0.00662	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—UTS2—atherosclerosis	0.00658	0.00658	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CX3CR1—atherosclerosis	0.00631	0.00631	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CASR—atherosclerosis	0.00631	0.00631	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CX3CL1—atherosclerosis	0.00619	0.00619	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00599	0.00599	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00599	0.00599	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00595	0.00595	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CNR2—atherosclerosis	0.00587	0.00587	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00584	0.00584	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—HRH1—atherosclerosis	0.00577	0.00577	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—HRH1—atherosclerosis	0.00524	0.00524	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00512	0.00512	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00509	0.00509	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CCL3—atherosclerosis	0.00504	0.00504	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CCR2—atherosclerosis	0.00456	0.00456	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—EDNRA—atherosclerosis	0.00456	0.00456	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—GHRL—atherosclerosis	0.00445	0.00445	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00432	0.00432	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00429	0.00429	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—KNG1—atherosclerosis	0.0039	0.0039	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—AGTR1—atherosclerosis	0.00388	0.00388	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CCL4—atherosclerosis	0.00379	0.00379	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—UTS2—atherosclerosis	0.00372	0.00372	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00358	0.00358	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—CASR—atherosclerosis	0.00357	0.00357	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—UTS2—atherosclerosis	0.00338	0.00338	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—CNR2—atherosclerosis	0.00332	0.00332	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00331	0.00331	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—EDN1—atherosclerosis	0.00329	0.00329	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CCL5—atherosclerosis	0.00326	0.00326	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CX3CR1—atherosclerosis	0.00324	0.00324	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CASR—atherosclerosis	0.00324	0.00324	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CX3CL1—atherosclerosis	0.00318	0.00318	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—HRH1—atherosclerosis	0.0031	0.0031	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CNR2—atherosclerosis	0.00301	0.00301	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00295	0.00295	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—AGT—atherosclerosis	0.00273	0.00273	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CCL3—atherosclerosis	0.00259	0.00259	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—CCR2—atherosclerosis	0.00258	0.00258	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—EDNRA—atherosclerosis	0.00258	0.00258	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—F2—atherosclerosis	0.00252	0.00252	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—GHRL—atherosclerosis	0.00251	0.00251	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOA4—atherosclerosis	0.00243	0.00243	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CCR2—atherosclerosis	0.00234	0.00234	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—EDNRA—atherosclerosis	0.00234	0.00234	CbGpPWpGaD
Roxatidine acetate—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00233	0.00233	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—GHRL—atherosclerosis	0.00228	0.00228	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CCL2—atherosclerosis	0.00225	0.00225	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CCL4—atherosclerosis	0.00224	0.00224	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—KNG1—atherosclerosis	0.00221	0.00221	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—AGTR1—atherosclerosis	0.00219	0.00219	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOA2—atherosclerosis	0.00209	0.00209	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—KNG1—atherosclerosis	0.002	0.002	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—UTS2—atherosclerosis	0.002	0.002	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—AGTR1—atherosclerosis	0.00199	0.00199	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CX3CR1—atherosclerosis	0.00191	0.00191	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CASR—atherosclerosis	0.00191	0.00191	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CX3CL1—atherosclerosis	0.00188	0.00188	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—EDN1—atherosclerosis	0.00186	0.00186	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—CCL5—atherosclerosis	0.00184	0.00184	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CNR2—atherosclerosis	0.00178	0.00178	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR ligand binding—CXCL8—atherosclerosis	0.00178	0.00178	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—MMP3—atherosclerosis	0.00177	0.00177	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—PRKCG—atherosclerosis	0.00175	0.00175	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—EDN1—atherosclerosis	0.00169	0.00169	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CCL5—atherosclerosis	0.00167	0.00167	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—PRKCG—atherosclerosis	0.00159	0.00159	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—VWF—atherosclerosis	0.00159	0.00159	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOC3—atherosclerosis	0.00158	0.00158	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—LDLR—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—AGT—atherosclerosis	0.00154	0.00154	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CCL3—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—NCF1—atherosclerosis	0.00146	0.00146	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—F2—atherosclerosis	0.00143	0.00143	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—AGT—atherosclerosis	0.0014	0.0014	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CCR2—atherosclerosis	0.00138	0.00138	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—EDNRA—atherosclerosis	0.00138	0.00138	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CYBA—atherosclerosis	0.00138	0.00138	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00136	0.00136	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PLAT—atherosclerosis	0.00135	0.00135	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PARP1—atherosclerosis	0.00135	0.00135	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—GHRL—atherosclerosis	0.00135	0.00135	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—F2—atherosclerosis	0.00129	0.00129	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—PIK3CG—atherosclerosis	0.00124	0.00124	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—KNG1—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—AGTR1—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CCL2—atherosclerosis	0.00115	0.00115	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PLG—atherosclerosis	0.00115	0.00115	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—SOCS3—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—MMP3—atherosclerosis	0.00105	0.00105	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—IGF2—atherosclerosis	0.00104	0.00104	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOB—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—CXCL8—atherosclerosis	0.001	0.001	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—EDN1—atherosclerosis	0.000997	0.000997	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CCL5—atherosclerosis	0.000989	0.000989	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—LPL—atherosclerosis	0.000967	0.000967	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PRKCG—atherosclerosis	0.00094	0.00094	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—SPP1—atherosclerosis	0.000916	0.000916	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—CXCL8—atherosclerosis	0.000912	0.000912	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PDGFB—atherosclerosis	0.000848	0.000848	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—AGT—atherosclerosis	0.000828	0.000828	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—LEP—atherosclerosis	0.000811	0.000811	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOE—atherosclerosis	0.000811	0.000811	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CAV1—atherosclerosis	0.000803	0.000803	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—APOA1—atherosclerosis	0.000802	0.000802	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—ESR1—atherosclerosis	0.000774	0.000774	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—F2—atherosclerosis	0.000765	0.000765	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—PIK3CG—atherosclerosis	0.000732	0.000732	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—MAPK3—atherosclerosis	0.000701	0.000701	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—INS—atherosclerosis	0.000693	0.000693	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CCL2—atherosclerosis	0.000682	0.000682	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—IGF1—atherosclerosis	0.00067	0.00067	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—SERPINE1—atherosclerosis	0.000636	0.000636	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—NOS3—atherosclerosis	0.000607	0.000607	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—CXCL8—atherosclerosis	0.000539	0.000539	CbGpPWpGaD
Roxatidine acetate—HRH2—GPCR downstream signaling—AKT1—atherosclerosis	0.000521	0.000521	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—IL6—atherosclerosis	0.000512	0.000512	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—MMP9—atherosclerosis	0.000487	0.000487	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—NFKB1—atherosclerosis	0.000482	0.000482	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—MAPK8—atherosclerosis	0.000474	0.000474	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling by GPCR—AKT1—atherosclerosis	0.000473	0.000473	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—VEGFA—atherosclerosis	0.000438	0.000438	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—STAT3—atherosclerosis	0.000433	0.000433	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—MAPK3—atherosclerosis	0.000414	0.000414	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—TGFB1—atherosclerosis	0.000402	0.000402	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—IL6—atherosclerosis	0.000303	0.000303	CbGpPWpGaD
Roxatidine acetate—HRH2—Signaling Pathways—AKT1—atherosclerosis	0.000279	0.000279	CbGpPWpGaD
